A supercomputer will examine a cancer patient's DNA to select the best personalized treatment plan to battle their particular cancer. IBM says 14 U.S. cancer treatment centers will take part in an initial partnership.
A supercomputer will examine a cancer patient's DNA to select the best personalized treatment plan to battle their particular cancer. IBM says 14 U.S. cancer treatment centers will take part in an initial partnership.